TYENNE
TYENNE
Approved
DIN Number
02552477
Drug Class
Human
Market Date
Apr 14, 2025
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02552477
AIG Number0152713001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC07 TOCILIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TOCILIZUMABActive
Strength: 400 MG / 20 ML
Monograph: TOCILIZUMAB